D1/5 receptor-mediated enhancement of LTP requires PKA, Src family kinases, and NR2B-containing NMDARs. [electronic resource]
Producer: 20090115Description: 871-7 p. digitalISSN:- 0028-3908
- 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine -- pharmacology
- Animals
- Animals, Newborn
- Cyclic AMP-Dependent Protein Kinases -- physiology
- Dopamine Agonists -- pharmacology
- Dose-Response Relationship, Drug
- Drug Interactions
- Electric Stimulation -- methods
- Enzyme Inhibitors -- pharmacology
- Hippocampus -- drug effects
- In Vitro Techniques
- Long-Term Potentiation -- drug effects
- Male
- Phenols -- pharmacology
- Piperidines -- pharmacology
- Rats
- Rats, Sprague-Dawley
- Receptors, Dopamine D1 -- physiology
- Receptors, N-Methyl-D-Aspartate -- antagonists & inhibitors
- src-Family Kinases -- physiology
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.